--- title: "BPC-157 vs TB-500 — Head-to-Head Comparison for Recovery" description: "BPC-157 vs TB-500 compared: mechanisms, research evidence, dosing, stacking protocols, pricing, and which is better for your goals. 15+ PubMed citations." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Article", "headline": "BPC-157 vs TB-500 — Head-to-Head Comparison for Recovery", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/bhglogo.png" } }, "datePublished": "2026-04-12", "dateModified": "2026-04-12", "mainEntityOfPage": "https://www.bodyhackguide.co/blog/bpc-157-vs-tb-500", "wordCount": 4200, "timeRequired": "PT16M" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Can you stack BPC-157 and TB-500 together?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. BPC-157 and TB-500 operate through entirely different receptor systems and mechanisms. BPC-157 modulates nitric oxide and VEGFR2 while TB-500 regulates actin polymerization and NF-kB. There is no receptor competition, and many in the research community combine them for additive tissue repair effects." } }, { "@type": "Question", "name": "Which is better for tendon injuries?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 has stronger and more specific evidence for tendon and ligament healing. Multiple animal studies demonstrate accelerated Achilles tendon healing, increased tendon fibroblast growth hormone receptor expression, and enhanced collagen production. TB-500 supports general tissue repair but has fewer tendon-specific studies." } }, { "@type": "Question", "name": "Which is better for gut healing?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is the clear choice for gastrointestinal applications. It is derived from a protein found in human gastric juice, has extensive research in ulcer healing, IBD models, and mucosal protection. TB-500 has no significant GI-specific research." } }, { "@type": "Question", "name": "Do BPC-157 and TB-500 have the same mechanism?", "acceptedAnswer": { "@type": "Answer", "text": "No. They work through completely different pathways. BPC-157 primarily modulates the nitric oxide system, upregulates VEGFR2 for angiogenesis, and stimulates EGR-1 gene expression. TB-500 sequesters G-actin monomers to promote cytoskeletal remodeling, cell migration, and downregulates the NF-kB inflammatory pathway." } }, { "@type": "Question", "name": "How long does it take for BPC-157 to work?", "acceptedAnswer": { "@type": "Answer", "text": "In animal models, measurable tissue repair effects appear within days to weeks depending on the injury type. Community reports typically describe noticeable improvements in tendon and joint discomfort within 1 to 2 weeks of consistent dosing. GI effects may appear sooner, sometimes within the first week." } }, { "@type": "Question", "name": "How long does it take for TB-500 to work?", "acceptedAnswer": { "@type": "Answer", "text": "TB-500 generally takes longer to show effects compared to BPC-157. Community reports suggest 1 to 2 weeks before noticeable systemic anti-inflammatory effects and 3 to 4 weeks for structural tissue repair. The loading phase of 2x per week dosing for the first 4 to 6 weeks is considered important for building effective tissue levels." } }, { "@type": "Question", "name": "Are BPC-157 and TB-500 legal?", "acceptedAnswer": { "@type": "Answer", "text": "Neither BPC-157 nor TB-500 is FDA approved for human use. Both are classified as research chemicals in most jurisdictions. BPC-157 falls under WADA S0 (non-approved substances) and TB-500 under WADA S2 (peptide hormones and related substances). Both are prohibited in competitive sport. Regulations vary by country." } }, { "@type": "Question", "name": "Can you take BPC-157 orally?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, there is research supporting oral administration of BPC-157. Oral bioavailability is lower than injection for systemic effects, but oral dosing may be more effective for gastrointestinal conditions since the peptide contacts GI tissue directly. TB-500 does not have meaningful oral bioavailability and is administered by injection only." } }, { "@type": "Question", "name": "What is the Wolverine Stack?", "acceptedAnswer": { "@type": "Answer", "text": "The Wolverine Stack is the popular name for combining BPC-157 and TB-500 together for maximum recovery. A typical protocol uses BPC-157 at 250mcg twice daily subcutaneously near the injury site plus TB-500 at 2.5mg twice per week subcutaneously anywhere. The name references the fictional character's extreme regenerative ability." } }, { "@type": "Question", "name": "Which is cheaper per month?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is significantly cheaper per month. At typical dosing of 250 to 500mcg per day, a 5mg vial lasts 10 to 20 days, costing roughly $37 to $130 per month. TB-500 requires much larger doses of 2.5 to 5mg per injection twice weekly, making monthly costs $136 to $440. The Wolverine Stack combining both runs $173 to $570 per month." } } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Blog", "item": "https://www.bodyhackguide.co/blog" }, { "@type": "ListItem", "position": 3, "name": "BPC-157 vs TB-500", "item": "https://www.bodyhackguide.co/blog/bpc-157-vs-tb-500" } ] }, { "@context": "https://schema.org", "@type": "Article", "headline": "BPC-157 vs TB-500 — Head-to-Head Comparison for Recovery", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/bhglogo.png" } }, "datePublished": "2026-04-12", "dateModified": "2026-04-12", "mainEntityOfPage": "https://www.bodyhackguide.co/blog/bpc-157-vs-tb-500", "wordCount": 4200, "timeRequired": "PT16M" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Can you stack BPC-157 and TB-500 together?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. BPC-157 and TB-500 operate through entirely different receptor systems and mechanisms. BPC-157 modulates nitric oxide and VEGFR2 while TB-500 regulates actin polymerization and NF-kB. There is no receptor competition, and many in the research community combine them for additive tissue repair effects." } }, { "@type": "Question", "name": "Which is better for tendon injuries?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 has stronger and more specific evidence for tendon and ligament healing. Multiple animal studies demonstrate accelerated Achilles tendon healing, increased tendon fibroblast growth hormone receptor expression, and enhanced collagen production. TB-500 supports general tissue repair but has fewer tendon-specific studies." } }, { "@type": "Question", "name": "Which is better for gut healing?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is the clear choice for gastrointestinal applications. It is derived from a protein found in human gastric juice, has extensive research in ulcer healing, IBD models, and mucosal protection. TB-500 has no significant GI-specific research." } }, { "@type": "Question", "name": "Do BPC-157 and TB-500 have the same mechanism?", "acceptedAnswer": { "@type": "Answer", "text": "No. They work through completely different pathways. BPC-157 primarily modulates the nitric oxide system, upregulates VEGFR2 for angiogenesis, and stimulates EGR-1 gene expression. TB-500 sequesters G-actin monomers to promote cytoskeletal remodeling, cell migration, and downregulates the NF-kB inflammatory pathway." } }, { "@type": "Question", "name": "How long does it take for BPC-157 to work?", "acceptedAnswer": { "@type": "Answer", "text": "In animal models, measurable tissue repair effects appear within days to weeks depending on the injury type. Community reports typically describe noticeable improvements in tendon and joint discomfort within 1 to 2 weeks of consistent dosing. GI effects may appear sooner, sometimes within the first week." } }, { "@type": "Question", "name": "How long does it take for TB-500 to work?", "acceptedAnswer": { "@type": "Answer", "text": "TB-500 generally takes longer to show effects compared to BPC-157. Community reports suggest 1 to 2 weeks before noticeable systemic anti-inflammatory effects and 3 to 4 weeks for structural tissue repair. The loading phase of 2x per week dosing for the first 4 to 6 weeks is considered important for building effective tissue levels." } }, { "@type": "Question", "name": "Are BPC-157 and TB-500 legal?", "acceptedAnswer": { "@type": "Answer", "text": "Neither BPC-157 nor TB-500 is FDA approved for human use. Both are classified as research chemicals in most jurisdictions. BPC-157 falls under WADA S0 (non-approved substances) and TB-500 under WADA S2 (peptide hormones and related substances). Both are prohibited in competitive sport. Regulations vary by country." } }, { "@type": "Question", "name": "Can you take BPC-157 orally?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, there is research supporting oral administration of BPC-157. Oral bioavailability is lower than injection for systemic effects, but oral dosing may be more effective for gastrointestinal conditions since the peptide contacts GI tissue directly. TB-500 does not have meaningful oral bioavailability and is administered by injection only." } }, { "@type": "Question", "name": "What is the Wolverine Stack?", "acceptedAnswer": { "@type": "Answer", "text": "The Wolverine Stack is the popular name for combining BPC-157 and TB-500 together for maximum recovery. A typical protocol uses BPC-157 at 250mcg twice daily subcutaneously near the injury site plus TB-500 at 2.5mg twice per week subcutaneously anywhere. The name references the fictional character's extreme regenerative ability." } }, { "@type": "Question", "name": "Which is cheaper per month?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is significantly cheaper per month. At typical dosing of 250 to 500mcg per day, a 5mg vial lasts 10 to 20 days, costing roughly $37 to $130 per month. TB-500 requires much larger doses of 2.5 to 5mg per injection twice weekly, making monthly costs $136 to $440. The Wolverine Stack combining both runs $173 to $570 per month." } } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Blog", "item": "https://www.bodyhackguide.co/blog" }, { "@type": "ListItem", "position": 3, "name": "BPC-157 vs TB-500", "item": "https://www.bodyhackguide.co/blog/bpc-157-vs-tb-500" } ] } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+ — Enter SiteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fblog%2Fbpc-157-vs-tb-500) 100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) [Home](/)/ [Blog](/blog)/ BPC-157 vs TB-500 Comparison Recovery 16 min read April 12, 2026 # BPC-157 vs TB-500 Head-to-Head Comparison for Recovery Two of the most popular research peptides for healing — compared on mechanism, evidence, dosing, cost, and when to use each. C BioChonch Research Editor · BodyHackGuide The Verdict Jump to section For research and educational purposes only. Not medical advice. Neither BPC-157 nor TB-500 is FDA approved. Always consult a qualified healthcare provider before using any research peptide. BPC-157 and TB-500 are the two most discussed peptides in the recovery and biohacking space. Both show remarkable tissue-repair properties in research. Both are used extensively in the community. But they are not the same compound, they do not work the same way, and they are not interchangeable. This guide compares them head-to-head across every dimension that matters: mechanism of action, strength of evidence, dosing protocols, cost, side effects, and which injuries or conditions each one is better suited for. If you are trying to decide between them — or wondering whether to stack both — this is the breakdown you need. ## The Verdict — Answer First BPC-157 wins for tendon, ligament, and gut healing. It has 90+ published studies, stronger musculoskeletal evidence, an oral dosing option, and costs significantly less per month. TB-500 wins for cardiac repair, systemic inflammation, and wound healing. It has 60+ studies, unique actin-regulation mechanism, and the strongest cardiac-specific data of any research peptide. They work through completely different mechanisms — BPC-157 via NO modulation and VEGFR2 upregulation, TB-500 via actin sequestration and NF-kB downregulation. No receptor competition. They are frequently stacked together (the "Wolverine Stack") for synergistic tissue repair across both local and systemic pathways. Tendon / Gut Injury Choose BPC-157 Cardiac / Systemic Choose TB-500 Maximum Recovery Stack Both ## What They Are Before comparing them, you need to understand what each compound actually is at the molecular level. Despite being grouped together as "healing peptides," they come from entirely different biological origins. ### BPC-157 Full Name Body Protection Compound-157 Type 15-amino acid pentadecapeptide Origin Human gastric juice CAS 137525-51-0 Molecular Weight 1419.53 Da PubMed Studies 90+ Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val [View foundational research](https://pubmed.ncbi.nlm.nih.gov/21524250) ### TB-500 Full Name Thymosin Beta-4 Fragment Type 43-amino acid peptide Origin Thymus gland (all tissues) Parent Protein Thymosin beta-4 (Tβ4) Molecular Weight 4963 Da PubMed Studies 60+ Naturally occurring in nearly all human tissues and cell types [View foundational research](https://pubmed.ncbi.nlm.nih.gov/20549306) BPC-157 is a synthetic fragment of a larger protein found naturally in human gastric juice. It was first isolated and characterized by researchers at the University of Zagreb. The 15-amino acid sequence does not exist as a standalone molecule in the body — it is a fragment that was identified for its potent cytoprotective properties and then synthesized for research use. TB-500 is a synthetic version of a naturally occurring 43-amino acid peptide called thymosin beta-4. Unlike BPC-157, thymosin beta-4 exists abundantly throughout the human body. It is one of the most prevalent intracellular peptides, found in virtually every tissue and cell type. TB-500 replicates the full sequence of the naturally occurring molecule. Both BPC-157 and TB-500 are research chemicals. Neither is FDA approved for any human use. They are not supplements, medications, or treatments. All efficacy data comes from preclinical (animal) studies. Use in humans is experimental and carries inherent risks. ## Head-to-Head Comparison The full side-by-side breakdown across every metric that matters for making a decision. Metric BPC-157 TB-500 Classification Gastric pentadecapeptide Thymosin beta-4 fragment Primary Mechanism NO modulation / VEGFR2 Actin sequestration / angiogenesis Research Volume 90+ PubMed studies 60+ PubMed studies Best Studied For Tendon / GI / Nerve Cardiac / Wound / Hair Administration Routes SubQ / Oral / IP SubQ / IM Typical Research Dose 250-500 mcg/day 2-5 mg 2x/week Half-Life ~4 hours ~6 hours Cycle Length 4-8 weeks 4-8 weeks WADA Status Prohibited S0 Prohibited S2 FDA Status Not approved Not approved Cost (5mg vial) $37-65 $34-55 Onset of Effects Days to weeks 1-2 weeks The most important difference visible in the table is the dosing. BPC-157 uses microgram doses (250-500 mcg) while TB-500 uses milligram doses (2-5 mg). This single fact drives the entire cost difference between the two compounds and is the primary reason BPC-157 is more cost-effective for most applications. ## How They Work — Side by Side Understanding the mechanisms is critical because it explains why they are effective for different conditions and why combining them produces additive effects rather than redundancy. ### BPC-157: Nitric Oxide and Growth Factor Modulation BPC-157 operates primarily through the nitric oxide (NO) system. It modulates NO synthesis in a context-dependent manner — increasing NO where levels are depleted (promoting vasodilation and blood flow to injured tissue) and counteracting NO excess where it causes damage (protecting against NSAID-induced gastropathy and oxidative stress). This bidirectional NO modulation is one of the most distinctive features of BPC-157 and explains its remarkably broad therapeutic window in animal models. A second major pathway involves VEGFR2 (vascular endothelial growth factor receptor 2) upregulation. BPC-157 stimulates the formation of new blood vessels through VEGFR2-dependent angiogenesis, which is essential for delivering nutrients and oxygen to damaged tissue. Research demonstrates that BPC-157 increases VEGFR2 expression in tendon fibroblasts and endothelial cells, directly accelerating the vascular component of tissue repair ([PMID: 21524250](https://pubmed.ncbi.nlm.nih.gov/21524250)). BPC-157 also activates the EGR-1 (early growth response-1) gene, a transcription factor that triggers downstream expression of growth factors, cytokines, and extracellular matrix proteins critical for wound repair. Additionally, it enhances growth hormone receptor expression in tendon fibroblasts ([PMID: 30175840](https://pubmed.ncbi.nlm.nih.gov/30175840)), upregulates the FAK-paxillin signaling pathway to promote cell migration and adhesion, and interacts with both the dopaminergic and serotonergic systems — giving it neuroprotective properties that extend beyond pure tissue repair. The neuroprotective dimension is often overlooked. BPC-157 has been shown to counteract dopamine system disturbances, protect against serotonin-depleting agents, and accelerate recovery from peripheral nerve crush injuries in animal models. This makes it one of the few research peptides with demonstrated activity across musculoskeletal, gastrointestinal, and neurological tissue systems. ### TB-500: Actin Regulation and Anti-Inflammatory Signaling TB-500 works through an entirely different mechanism centered on actin biology. Its primary action is G-actin sequestration — it binds to monomeric (globular) actin and prevents premature polymerization into filaments. This might sound counterintuitive for a healing peptide, but the controlled regulation of actin dynamics is essential for cell migration, a process fundamental to all tissue repair. By maintaining a pool of available actin monomers, TB-500 ensures that cells can rapidly reorganize their cytoskeleton when they need to move to a wound site. Beyond actin regulation, TB-500 is a potent anti-inflammatory agent that operates through downregulation of the NF-kB (nuclear factor kappa-B) pathway. NF-kB is a master transcription factor that controls the expression of hundreds of pro-inflammatory genes. By suppressing NF-kB activation, TB-500 reduces the production of inflammatory cytokines like TNF-alpha, IL-1, and IL-6. This systemic anti-inflammatory effect is one reason TB-500 is favored for conditions involving widespread inflammation rather than localized injury. TB-500 also promotes angiogenesis, but through a pathway distinct from BPC-157. While BPC-157 relies on VEGFR2, TB-500 stimulates new blood vessel formation through VEGF-independent mechanisms involving endothelial cell migration and tubule formation. This means the two compounds promote angiogenesis through non-overlapping pathways — a key reason their combination is considered synergistic rather than redundant. The cardiac application of TB-500 is particularly noteworthy. Research demonstrates that thymosin beta-4 promotes cardiomyocyte survival following ischemic injury, activates cardiac progenitor cells, and reduces fibrosis (scar tissue) in damaged heart tissue ([PMID: 18286466](https://pubmed.ncbi.nlm.nih.gov/18286466)). These cardioprotective effects have made TB-500 the subject of considerable interest in regenerative cardiology research and represent one of the strongest evidence bases for any research peptide in a specific organ system. ## Research Evidence Both compounds have substantial preclinical evidence but in different areas. Here is where the research is strongest for each. ### BPC-157 Evidence by System #### Musculoskeletal Accelerated Achilles tendon healing, increased tendon-to-bone strength, enhanced collagen organization in ligament models, faster muscle healing after crush injury. This is the most extensively studied application with the strongest evidence base. [PMID: 30915550](https://pubmed.ncbi.nlm.nih.gov/30915550) #### Gastrointestinal Mucosal protection against NSAID-induced damage, accelerated ulcer healing, improved intestinal barrier function in inflammatory bowel disease models, cytoprotection of gastric mucosa across multiple injury models. [PMID: 29898088](https://pubmed.ncbi.nlm.nih.gov/29898088) #### Neurological Counteraction of dopamine system disturbances, peripheral nerve regeneration, spinal cord injury models, protection against serotonin-depleting agents, anxiolytic-like effects in behavioral models. [PMID: 21524250](https://pubmed.ncbi.nlm.nih.gov/21524250) #### Wound Healing Accelerated cutaneous wound closure, increased granulation tissue formation, improved angiogenesis at wound sites. Effects documented across multiple species and wound types. ### TB-500 Evidence by System #### Cardiac Repair Cardiomyocyte survival after ischemic injury, cardiac progenitor cell activation, reduced myocardial fibrosis, improved ejection fraction in post-infarction models. The strongest body of evidence for TB-500 in any single organ system. [PMID: 18286466](https://pubmed.ncbi.nlm.nih.gov/18286466) #### Wound Healing Accelerated full-thickness wound closure, enhanced keratinocyte and endothelial cell migration, improved wound bed vascularization, reduced inflammation at wound margins. [PMID: 25613625](https://pubmed.ncbi.nlm.nih.gov/25613625) #### Corneal Healing Accelerated corneal re-epithelialization, reduced corneal inflammation, improved outcomes in alkali burn models. One of the more clinically advanced applications of thymosin beta-4 research. #### Dermal / Hair Growth Stimulation of hair follicle stem cells, promotion of hair growth in animal models, acceleration of dermal repair. The hair growth finding was incidental to wound healing research but has generated significant community interest. ### Evidence Strength Comparison BPC-157 has a broader evidence base across more biological systems. It has been studied in musculoskeletal, gastrointestinal, neurological, and vascular models with consistent positive results. TB-500 has a narrower but deeper evidence base, with particularly strong data in cardiac repair and wound healing. For researchers interested in any single tissue system, BPC-157 generally has more published papers to draw from. For cardiac-specific applications, TB-500 has the stronger dataset. Critical caveat: Neither compound has completed Phase 3 human clinical trials. All dosing and efficacy data is extrapolated from animal models. BPC-157 has one published IV pilot safety study in human subjects ([PMID: 40131143](https://pubmed.ncbi.nlm.nih.gov/40131143)), but large-scale human efficacy trials do not exist for either compound. ## Dosing Protocols Dosing is one of the biggest practical differences between these two peptides. BPC-157 uses microgram-level doses administered daily, while TB-500 uses milligram-level doses administered less frequently. ### BPC-157 Dosing Dose: 250-500 mcg subcutaneous, 1-2x daily Reconstitution: 5mg vial + 2mL BAC water = 2.5mg/mL For 250mcg: 10 units on U-100 syringe Injection: SubQ, near injury site or abdomen Cycle: 4-8 weeks [BPC-157 Calculator](/tools/reconstitution/bpc-157) ### TB-500 Dosing Loading: 2.5-5mg SubQ, 2x per week for 4-6 weeks Maintenance: 2.5mg 1x per week Reconstitution: 5mg vial + 2mL BAC water = 2.5mg/mL Injection: SubQ, any site (systemic) Cycle: 4-8 weeks loading, then maintenance [TB-500 Calculator](/tools/reconstitution/tb-500) The dosing frequency difference is significant for practical compliance. BPC-157 requires daily injections (or twice daily for higher protocols), while TB-500 only requires injections twice per week during loading and once per week during maintenance. People who dislike frequent injections may prefer the TB-500 schedule. BPC-157 has the unique advantage of oral bioavailability. While subcutaneous injection remains the most common administration route, oral dosing has been studied and shown efficacy, particularly for gastrointestinal applications. TB-500 has no meaningful oral bioavailability and must be injected. Another practical difference is injection site. BPC-157 is commonly injected near the injury site under the rationale that local concentration will be higher, although systemic distribution occurs regardless of injection location. TB-500 is injected anywhere subcutaneously because its mechanism is inherently systemic — it acts on the cytoskeleton of all cells, not just those near the injection site. ## Stacking BPC-157 + TB-500 The combination of BPC-157 and TB-500 has earned the nickname "The Wolverine Stack" in the biohacking community — a reference to the fictional character known for extreme regenerative ability. It is the most popular recovery peptide stack by a wide margin. ### Why the Stack Works (Mechanistic Rationale) The combination is considered synergistic rather than redundant because the two peptides operate through entirely different receptor systems and molecular pathways. BPC-157 provides local tissue repair through NO modulation, VEGFR2-dependent angiogenesis, and growth factor receptor upregulation. TB-500 provides systemic support through actin-mediated cell migration, NF-kB-mediated anti-inflammatory signaling, and VEGF-independent angiogenesis. Because they target different receptors, there is no competition for binding sites. Both promote angiogenesis but through independent pathways (VEGFR2 vs. actin-driven endothelial migration), meaning the combined angiogenic stimulus is additive. BPC-157 handles the local repair cascade at the injury site while TB-500 handles the systemic inflammatory environment and provides the cellular migration support that brings repair cells to the damaged area. ### Community Stacking Protocol BPC-157: 250 mcg subcutaneous, 2x daily (near injury site) TB-500: 2.5 mg subcutaneous, 2x per week (any site) Duration: 4-8 weeks Storage: Both reconstituted separately, stored refrigerated at 2-8 C There is no published clinical data on the BPC-157 + TB-500 combination in humans. The stacking rationale is based on individual compound mechanisms and community experience. The combination has not been studied for safety or efficacy as a pair. Proceed with appropriate caution. [BPC-157/TB-500 Blend Profile](/compound/bpc-tb-blend) ## Pricing Comparison Per-vial pricing is similar, but the monthly cost is dramatically different because TB-500 requires much larger doses. This is the number one surprise for people new to these peptides. Metric BPC-157 (5mg) TB-500 (5mg) Wolverine Stack Price range $37-65 $34-55 $71-120 Doses per vial 10-20 (at 250-500mcg) 1-2 (at 2.5-5mg) — Monthly cost $37-130 $136-440 $173-570 The cost difference is entirely driven by dosing requirements. A single 5mg vial of BPC-157 contains 10-20 individual doses at the typical 250-500 mcg range. A single 5mg vial of TB-500 contains only 1-2 doses at the typical 2.5-5 mg range. You burn through TB-500 vials roughly 10x faster than BPC-157 vials. For budget-conscious researchers, BPC-157 is the clear winner on a per-month basis. For localized musculoskeletal injuries where BPC-157 has strong evidence, the cost advantage is compounded by the stronger relevant research base. TB-500 becomes more cost-justifiable when the specific application (cardiac, systemic inflammation, wound healing) aligns with its stronger evidence areas. The Wolverine Stack combining both peptides is the most expensive option at $173-570 per month depending on dosing and vendor, but it targets the widest range of recovery mechanisms simultaneously. [Compare Vendor Prices](/compare) ## Who Should Use What The final decision comes down to your specific situation. Here is the decision framework based on the evidence and mechanisms covered above. ### Use BPC-157 If: Tendon or ligament injury Gut issues (IBD, leaky gut, ulcers) Nerve recovery or neuroprotection You want an oral dosing option Budget is a primary concern You prefer daily micro-dosing Localized injury rather than systemic ### Use TB-500 If: Systemic inflammation Cardiac health concerns Wound healing or skin repair Hair loss / follicle recovery Post-surgery whole-body recovery You prefer less frequent injections Systemic rather than localized condition ### Use Both (Wolverine Stack) If: Serious injury requiring maximum recovery Post-surgical rehabilitation Chronic pain with inflammatory component Multiple injury types simultaneously Budget is not the primary constraint You want broadest mechanism coverage ## Frequently Asked Questions Can you stack BPC-157 and TB-500 together? Which is better for tendon injuries? Which is better for gut healing? Do BPC-157 and TB-500 have the same mechanism? How long does it take for BPC-157 to work? How long does it take for TB-500 to work? Are BPC-157 and TB-500 legal? Can you take BPC-157 orally? What's the Wolverine Stack? Which is cheaper per month? ## Key Research Citations \[1\] Seiwerth S, et al. BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing, effect on angiogenesis. [PMID: 21524250](https://pubmed.ncbi.nlm.nih.gov/21524250) \[2\] Goldstein AL, et al. Thymosin beta-4: a multi-functional regenerative peptide. Basic properties and clinical applications. [PMID: 20549306](https://pubmed.ncbi.nlm.nih.gov/20549306) \[3\] Smart N, et al. Thymosin beta-4 and angiogenesis: modes of action and therapeutic potential. [PMID: 18286466](https://pubmed.ncbi.nlm.nih.gov/18286466) \[4\] Krivic A, et al. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. [PMID: 30915550](https://pubmed.ncbi.nlm.nih.gov/30915550) \[5\] Sikiric P, et al. Pentadecapeptide BPC 157 and its role in GI tract healing. [PMID: 29898088](https://pubmed.ncbi.nlm.nih.gov/29898088) \[6\] Chang CH, et al. BPC 157 enhances growth hormone receptor expression in tendon fibroblasts. [PMID: 30175840](https://pubmed.ncbi.nlm.nih.gov/30175840) \[7\] Philp D, et al. Thymosin beta-4 promotes dermal healing. [PMID: 25613625](https://pubmed.ncbi.nlm.nih.gov/25613625) \[8\] Sikiric P, et al. BPC 157 pilot safety study — intravenous administration in healthy volunteers. [PMID: 40131143](https://pubmed.ncbi.nlm.nih.gov/40131143) ## Related Guides [ ### BPC-157 Compound Profile Full research data and mechanism View ](/compound/bpc-157)[ ### TB-500 Compound Profile Full research data and mechanism View ](/compound/tb-500)[ ### BPC-157/TB-500 Blend Wolverine Stack blend profile View ](/compound/bpc-tb-blend)[ ### Reconstitution Calculator All peptides, any vial size View ](/tools/reconstitution) Disclaimer: This content is for research and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Neither BPC-157 nor TB-500 is approved by the FDA for any human use. Both are classified as research chemicals. Use of research-grade peptides carries inherent risks including contamination, inaccurate dosing, and unknown long-term effects. Always consult a qualified healthcare provider before using any research compound. BodyHackGuide does not sell, supply, or endorse the purchase of any controlled or investigational substance. Last updated: April 12, 2026 · Written by BioChonch · BodyHackGuide Research Team Share this article: [X / Twitter](https://twitter.com/intent/tweet?text=BPC-157%20vs%20TB-500%20%E2%80%94%20Head-to-Head%20Comparison%20for%20Recovery&url=https%3A%2F%2Fwww.bodyhackguide.co%2Fblog%2Fbpc-157-vs-tb-500) [ Related deep-dive comparison BPC-157 vs TB-500 Mechanism, dosing, head-to-head safety, cost, and 6 pair-specific FAQs View ](/compare/bpc-157-vs-tb-500) B [BioChonch](/about)Founder & Lead Researcher Researcher and founder of BodyHackGuide. Obsessed with evidence-based biohacking, peptide science, and nootropic protocols. Every recommendation is backed by PubMed citations and real-world testing. [](https://x.com/bodyhackguide)[](https://reddit.com/r/bodyhackguide)[](https://discord.gg/Mhq5UdRYBA)| [About the author](/about) Was this page helpful? Yes No [Back to all articles](/blog) On this page [The Verdict](#verdict)[What They Are](#what-they-are)[Head-to-Head Comparison](#head-to-head)[How They Work](#mechanisms)[Research Evidence](#research)[Dosing Protocols](#dosing)[Stacking BPC-157 + TB-500](#stacking)[Pricing Comparison](#pricing)[Who Should Use What](#who-should-use)[FAQ](#faq) ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Dosage calculator](/tools/dosage) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Get BHG verified](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) [Shop BHG Labs · 20% off with BHG20](https://bhglabs.co/shop/?utm_source=reddit&utm_medium=paid&utm_campaign=bhg20_bridge&utm_content=sticky_mobile_bar&coupon=BHG20) hi 👋